{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T15:10:45Z","timestamp":1787238645372,"version":"build-2736575974"},"reference-count":36,"publisher":"Japanese Society for Lymphoreticular Tissue Research","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Clin Exp Hematopathol","JCEH"],"published-print":{"date-parts":[[2013]]},"DOI":"10.3960\/jslrt.53.69","type":"journal-article","created":{"date-parts":[[2013,6,20]],"date-time":"2013-06-20T19:26:52Z","timestamp":1371756412000},"page":"69-77","source":"Crossref","is-referenced-by-count":72,"title":["Clinical Features and Treatment of Multicentric Castleman's Disease : A Retrospective Study of 21 Japanese Patients at a Single Institute"],"prefix":"10.3960","volume":"53","author":[{"given":"Hiroshi","family":"Kawabata","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norimitsu","family":"Kadowaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Momoko","family":"Nishikori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshio","family":"Kitawaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tadakazu","family":"Kondo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takayuki","family":"Ishikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hajime","family":"Yoshifuji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noriyuki","family":"Yamakawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshitaka","family":"Imura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsuneyo","family":"Mimori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yumi","family":"Matsumura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiki","family":"Miyachi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Matsubara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Motoko","family":"Yanagita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hironori","family":"Haga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akifumi","family":"Takaori-Kondo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2349","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1 Castleman B, Iverson L, Menendez VP: Localized mediastinal lymphnode hyperplasia resembling thymoma. Cancer 9:822-830, 1956","DOI":"10.1002\/1097-0142(195607\/08)9:4<822::AID-CNCR2820090430>3.0.CO;2-4"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2 Keller AR, Hochholzer L, Castleman B: Hyaline-vascular and plasma-cell types of giant lymph node hyperplasia of the mediastinum and other locations. Cancer 29:670-683, 1972","DOI":"10.1002\/1097-0142(197203)29:3<670::AID-CNCR2820290321>3.0.CO;2-#"},{"key":"3","unstructured":"3 Bowne WB, Lewis JJ, Filippa DA, Niesvizky R, Brooks AD, <I>et al<\/I>.: The management of unicentric and multicentric Castleman's disease : A report of 16 cases and a review of the literature. Cancer 85:706-717, 1999"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4 Soulier J, Grollet L, Oksenhendler E, Cacoub P, Cazals-Hatem D, <I>et al<\/I>.: Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's disease. Blood 86:1276-1280, 1995","DOI":"10.1182\/blood.V86.4.1276.bloodjournal8641276"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5 Oksenhendler E, Carcelain G, Aoki Y, Boulanger E, Maillard A, <I>et al<\/I>.: High levels of human herpesvirus 8 viral load, human interleukin-6, interleukin-10, and C reactive protein correlate with exacerbation of multicentric Castleman disease in HIV-infected patients. Blood 96:2069-2073, 2000","DOI":"10.1182\/blood.V96.6.2069"},{"key":"6","unstructured":"6 Kojima M, Nakamura N, Tsukamoto N, Otuski Y, Shimizu K, <I>et al<\/I>.: Clinical implications of idiopathic multicentric Castleman disease among Japanese : A report of 28 cases. Int J Surg Pathol 16:391-398, 2008"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7 Cronin DM, Warnke RA: Castleman disease : An update on classification and the spectrum of associated lesions. Adv Anat Pathol 16:236-246, 2009","DOI":"10.1097\/PAP.0b013e3181a9d4d3"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8 Muskardin TW, Peterson BA, Molitor JA: Castleman disease and associated autoimmune disease. Curr Opin Rheumatol 24:76-83, 2012","DOI":"10.1097\/BOR.0b013e32834db525"},{"key":"9","unstructured":"9 Sato Y, Kojima M, Takata K, Morito T, Mizobuchi K, <I>et al<\/I>.: Multicentric Castleman's disease with abundant IgG4-positive cells : A clinical and pathological analysis of six cases. J Clin Pathol 63:1084-1089, 2010"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10 Nishimoto N, Kanakura Y, Aozasa K, Johkoh T, Nakamura M, <I>et al<\/I>.: Humanized anti-interleukin-6 receptor antibody treatment of multicentric Castleman disease. Blood 106:2627-2632, 2005","DOI":"10.1182\/blood-2004-12-4602"},{"key":"11","unstructured":"11 Kanda J, Kawabata H, Yamaji Y, Ichinohe T, Ishikawa T, <I>et al<\/I>.: Reversible cardiomyopathy associated with multicentric Castleman disease : Successful treatment with tocilizumab, an anti-interleukin 6 receptor antibody. Int J Hematol 85:207-211, 2007"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12 Kawabata H, Tomosugi N, Kanda J, Tanaka Y, Yoshizaki K, <I>et al<\/I>.: Anti-interleukin 6 receptor antibody tocilizumab reduces the level of serum hepcidin in patients with multicentric Castleman's disease. Haematologica 92:857-858, 2007","DOI":"10.3324\/haematol.10794"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13 Song SN, Tomosugi N, Kawabata H, Ishikawa T, Nishikawa T, <I>et al<\/I>.: Down-regulation of hepcidin resulting from long-term treatment with an anti-IL-6 receptor antibody (tocilizumab) improves anemia of inflammation in multicentric Castleman disease. Blood 116:3627-3634, 2010","DOI":"10.1182\/blood-2010-03-271791"},{"key":"14","unstructured":"14 Umehara H, Okazaki K, Masaki Y, Kawano M, Yamamoto M, <I>et al<\/I>.: A novel clinical entity, IgG4-related disease (IgG4RD) : General concept and details. Mod Rheumatol 22:1-14, 2012"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15 Ganz T: Molecular pathogenesis of anemia of chronic disease. Pediatr Blood Cancer 46:554-557, 2006","DOI":"10.1002\/pbc.20656"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16 Nishimoto N, Sasai M, Shima Y, Nakagawa M, Matsumoto T, <I>et al<\/I>.: Improvement in Castleman's disease by humanized anti-interleukin-6 receptor antibody therapy. Blood 95:56-61, 2000","DOI":"10.1182\/blood.V95.1.56.001k13_56_61"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17 Herrada J, Cabanillas F, Rice L, Manning J, Pugh W: The clinical behavior of localized and multicentric Castleman disease. Ann Intern Med 128:657-662, 1998","DOI":"10.7326\/0003-4819-128-8-199804150-00010"},{"key":"18","unstructured":"18 Ye B, Gao SG, Li W, Yang LH, Zhao SH, <I>et al<\/I>.: A retrospective study of unicentric and multicentric Castleman's disease : A report of 52 patients. Med Oncol 27:1171-1178, 2010"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19 Shin DY, Jeon YK, Hong YS, Kim TM, Lee SH, <I>et al<\/I>.: Clinical dissection of multicentric Castleman disease. Leuk Lymphoma 52:1517-1522, 2011","DOI":"10.3109\/10428194.2011.574759"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20 Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, <I>et al<\/I>.: The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25:1271-1277, 1982","DOI":"10.1002\/art.1780251101"},{"key":"21","unstructured":"21 Kojima M, Nakamura S, Morishita Y, Itoh H, Yoshida K, <I>et al<\/I>.: Reactive follicular hyperplasia in the lymph node lesions from systemic lupus erythematosus patients : A clinicopathological and immunohistological study of 21 cases. Pathol Int 50:304-312, 2000"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22 Kojima M, Motoori T, Nakamura S: Benign, atypical and malignant lymphoproliferative disorders in rheumatoid arthritis patients. Biomed Pharmacother 60:663-672, 2006","DOI":"10.1016\/j.biopha.2006.09.004"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23 Kojima M, Motoori T, Asano S, Nakamura S: Histological diversity of reactive and atypical proliferative lymph node lesions in systemic lupus erythematosus patients. Pathol Res Pract 203:423-431, 2007","DOI":"10.1016\/j.prp.2007.03.002"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24 Dispenzieri A: POEMS syndrome. Blood Rev 21:285-299, 2007","DOI":"10.1016\/j.blre.2007.07.004"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25 Dispenzieri A, Armitage JO, Loe MJ, Geyer SM, Allred J, <I>et al<\/I>.: The clinical spectrum of Castleman's disease. Am J Hematol 87:997-1002, 2012","DOI":"10.1002\/ajh.23291"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26 Yoshizaki K, Matsuda T, Nishimoto N, Kuritani T, Taeho L, <I>et al<\/I>.: Pathogenic significance of interleukin-6 (IL-6\/BSF-2) in Castleman's disease. Blood 74:1360-1367, 1989","DOI":"10.1182\/blood.V74.4.1360.bloodjournal7441360"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27 Karcher DS, Alkan S: Herpes-like DNA sequences, AIDS-related tumors, and Castleman's disease. N Engl J Med 333:797-798 ; Author reply 798-799, 1995","DOI":"10.1056\/NEJM199509213331211"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28 Dupin N, Diss TL, Kellam P, Tulliez M, Du MQ, <I>et al<\/I>.: HHV-8 is associated with a plasmablastic variant of Castleman disease that is linked to HHV-8-positive plasmablastic lymphoma. Blood 95:1406-1412, 2000","DOI":"10.1182\/blood.V95.4.1406.004k26_1406_1412"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29 Stebbing J, Adams C, Sanitt A, Mletzko S, Nelson M, <I>et al<\/I>.: Plasma HHV8 DNA predicts relapse in individuals with HIV-associated multicentric Castleman disease. Blood 118:271-275, 2011","DOI":"10.1182\/blood-2011-02-335620"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30 Nicholas J, Ruvolo V, Zong J, Ciufo D, Guo HG, <I>et al<\/I>.: A single 13-kilobase divergent locus in the Kaposi sarcoma-associated herpesvirus (human herpesvirus 8) genome contains nine open reading frames that are homologous to or related to cellular proteins. J Virol 71:1963-1974, 1997","DOI":"10.1128\/JVI.71.3.1963-1974.1997"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31 Suthaus J, Stuhlmann-Laeisz C, Tompkins VS, Rosean TR, Klapper W, <I>et al<\/I>.: HHV-8-encoded viral IL-6 collaborates with mouse IL-6 in the development of multicentric Castleman disease in mice. Blood 119:5173-5181, 2012","DOI":"10.1182\/blood-2011-09-377705"},{"key":"32","unstructured":"32 Orzechowska BU, Powers MF, Sprague J, Li H, Yen B, <I>et al<\/I>.: Rhesus macaque rhadinovirus-associated non-Hodgkin lymphoma : Animal model for KSHV-associated malignancies. Blood 112:4227-4234, 2008"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33 Schulte KM, Talat N: Castleman's disease - a two compartment model of HHV8 infection. Nat Rev Clin Oncol 7:533-543, 2010","DOI":"10.1038\/nrclinonc.2010.103"},{"key":"34","unstructured":"34 Kojima M, Nakamura N, Tsukamoto N, Yokohama A, Itoh H, <I>et al<\/I>.: Multicentric Castleman's disease representing effusion at initial clinical presentation : Clinicopathological study of seven cases. Lupus 20:44-50, 2011"},{"key":"35","unstructured":"35 Takai K, Nikkuni K, Shibuya H, Hashidate H: Thrombocytopenia with mild bone marrow fibrosis accompanied by fever, pleural effusion, ascites and hepatosplenomegaly. Rinsho Ketsueki 51:320-325, 2010 (<I>in Japanese<\/I>)"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36 Suthaus J, Adam N, Grotzinger J, Scheller J, Rose-John S: Viral interleukin-6 : Structure, pathophysiology and strategies of neutralization. Eur J Cell Biol 90:495-504, 2011","DOI":"10.1016\/j.ejcb.2010.10.016"}],"container-title":["Journal of Clinical and Experimental Hematopathology"],"original-title":[],"language":"en","deposited":{"date-parts":[[2021,5,20]],"date-time":"2021-05-20T15:46:37Z","timestamp":1621525597000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jslrt\/53\/1\/53_69\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.3960\/jslrt.53.69","relation":{},"ISSN":["1346-4280","1880-9952"],"issn-type":[{"value":"1346-4280","type":"print"},{"value":"1880-9952","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013]]}}}